The
Company’s reserved shares of common stock for future issuance related to potential conversion of the Convertible Preferred Stock,
exercise of Common Stock Warrants and exercise of stock options are as follows:
Schedule of Reserved Shares of Common Stock for Future Issuance
| | |
As
of December 31, 2025 | | |
As
of December 31, 2024 | |
| Convertible preferred stock (as
converted to common stock) | |
| - | | |
| 5,950,673 | |
| Common stock warrants | |
| 92,211 | | |
| 92,211 | |
| Common stock contingent obligation | |
| - | | |
| 29,611 | |
| Stock options | |
| 686,880 | | |
| 1,700,058 | |
| Equity shares warrant (refer note 22) | |
| 2,108,070 | | |
| - | |
| SPAC public and private placement warrants
(refer note 24) | |
| 13,458,750 | | |
| - | |
| Issuance of warrants pursuant to conversion of convertible note.(refer note 10) | |
| 30,000 | | |
| - | |
| Reserved shares of common
stock for future issuance | |
| 16,375,911 | | |
| 7,772,553 | (1) |
| (1) | | Includes 6,772
stock options as of December 31, 2024 that were legally exercised prior to meeting the service base vesting requirements in exchange
for nonrecourse promissory notes (Refer to “The Promissory Notes Transactions” in “Note 14 - Stock-based Compensation
“). |
|